LOADING
Tag: FDA
FDA Expands Label for Abrocitinib to Include Adolescents With … – MD Magazine
February 10, 2023
FDA Expands Label for Abrocitinib to Include Adolescents With … MD Magazine Source link
chat_bubble0 Comment
visibility313 Views
FDA approves new vitiligo treatment, bolstering Incyte’s dermatology business
July 19, 2022
The Food and Drug Administration has approved a first-of-its-kind treatment for vitiligo, a condition that causes patches of discoloration on the skin and, currently, has few other therapeutic options. The treatment, known as ruxolitinib, is now the only one approved in the U.S. to repigment skin in people with the most common, “nonsegmental” form of […]
chat_bubble0 Comment
visibility525 Views